stockrowSarepta Therapeutics, Inc.
SRPT Healthcare Biotechnology
Sarepta Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 15.6% from fiscal 2024.
- Revenue
- −4.51%
- EPS
- +46.0%
- Free cash flow
- +231.8%
- Total debt
- −17.2%
Quarter to September 2026, against a year earlier
Follow SRPT
Alert me
Sarepta Therapeutics, Inc. (SRPT) Current ratio
Sarepta Therapeutics, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.5×, up 1.1× from fiscal 2025 (2.3×). Over the past ten years it has ranged from 2.3× (fiscal 2025) to 13.9× (fiscal 2017) — the current reading is the lowest in ten years. That is below the Biotechnology industry median of 5.0× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 2.3× | (44.84%) |
| FY2024 | 4.2× | 6.45% |
| FY2023 | 3.9× | (4.41%) |
| FY2022 | 4.1× | (28.23%) |
| FY2021 | 5.8× | (3.71%) |
| FY2020 | 6.0× | 7.67% |
| FY2019 | 5.5× | (32.43%) |
| FY2018 | 8.2× | (40.97%) |
| FY2017 | 13.9× | 180.90% |
| FY2016 | 5.0× | 37.37% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 3.5× | (21.69%) |
| Jun 2026 | 4.4× | (4.44%) |
| Mar 2026 | 4.6× | 99.71% |
| Dec 2025 | 2.3× | (21.57%) |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| TRVI Trevi Therapeutics, Inc. compare | 37.3× |
| MAZE Maze Therapeutics, Inc. compare | 18.3× |
| TRAX First Tracks Biotherapeutics, Inc. compare | 9.2× |
| REPL Replimune Group, Inc. compare | 7.1× |
| VIR Vir Biotechnology, Inc. compare | 6.3× |
| MRVI Maravai LifeSciences Holdings, Inc. compare | 4.7× |
| SRPT Sarepta Therapeutics, Inc. | 3.5× |
| HRMY Harmony Biosciences Holdings, Inc. compare | 3.4× |
| MESO Mesoblast Limited compare | 1.6× |
| Biotechnology industry median | 5.0× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)